Interestingly, anti-CAII has been implicated in the pathogenesis of autoimmune diseases, such as systemic lupus erythematosus (SLE), SS, autoimmune cholangitis, autoimmune pancreatitis, and recently in Behcet’s disease (37–46). This evidence concerns the gene CA2 and autoimmune pancreatitis.